Abstract
Background: Vilsmeier-Haack formylation of N-arylacetamides and used them as a key intermediate for preparation of 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinoline-3- carbaldehydes. these used as precursors for the synthesis of 2-(piperidin-1-yl) and/ or 2-(morpholin- 1-yl) quinoline derivatives through the reaction with active methyl and/ or methylene component, Claisen-Schmidt condensation, one-pot multicomponent reactions (MCRs), reductive amination, Grignard reaction, etc.
Methods: This review demonstrates the synthesis of 2-chloroquinoline-3-carbaldehyde derivatives, through Vilsmeier-Haack formylation of N-arylacetamides that used as a precursor for preparation of 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinoline- 3-carbaldehydes and reacted them with various reagents to form the 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinolines derivatives.
Results: Many 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinolines derivatives were achived through the reaction with active methyl and/ or methylene component, Claisen-Schmidt condensation, one-pot multicomponent reactions (MCRs), reductive amination, Grignard reaction, etc….
Conclusion: Many quinoline ring systems, specifically concerning medicinal chemistry, had been published over the past decade. During this review, we have outlined the synthetic routes and reactions of 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinoline-3-carbaldehydes. This review implies a section of the synthesis of 2-(piperidin-1-yl) and/ or 2-(morpholin-1-yl) quinoline-3-carbaldehydes which can be prepared via Vilsmeier formylation of N-arylacetamides followed by heating of the formed aldehydes with piperidine or morpholine and two sections on its reactions with different reagents were presented. Eventually, this review focus upon 2-(piperidin-1-yl) and/ or 2-(morpholin-1- yl) quinoline-3-carbaldehydes as an interesting heterocyclic compound that can be utilized as a precursor and building block for the synthesis of an extended range of heterocyclic systems which have a potent pharmacological interest.
Keywords: 2-chloroquinoline-3-carbaldehyde, 2-(piperidin-1-yl) quinoline, 2-(morpholin-1-yl) quinoline, benzoimidazole, Claisen-Schmidt condensation, Vilsmeier-Haack.
[http://dx.doi.org/10.1016/S0140-6736(00)56672-0]
[http://dx.doi.org/10.1001/jama.1946.02870160015006]
[http://dx.doi.org/10.1126/science.1105787] [PMID: 1105787]
[http://dx.doi.org/10.1080/00397910008087076]
[http://dx.doi.org/10.1016/j.ejmech.2014.06.013] [PMID: 24996143]
[http://dx.doi.org/10.2174/157018013804142375]
[http://dx.doi.org/10.1134/S1070428020030203]
[http://dx.doi.org/10.3987/COM-07-11260]
[http://dx.doi.org/10.1016/j.cclet.2012.01.017]
[http://dx.doi.org/10.2478/s11696-011-0048-8]
[http://dx.doi.org/10.1016/j.ejmech.2016.02.016] [PMID: 26900659]
[http://dx.doi.org/10.1016/j.ica.2019.119130]
[http://dx.doi.org/10.1007/s11164-017-2981-9]
[http://dx.doi.org/10.1016/j.ejmech.2019.03.060] [PMID: 30959323]
[http://dx.doi.org/10.1002/chin.200605149]
[http://dx.doi.org/10.1002/jhet.2637]
[http://dx.doi.org/10.1002/jhet.4205]
[http://dx.doi.org/10.2174/1570193X18666210218212719]
[http://dx.doi.org/10.1002/jhet.4269]
[http://dx.doi.org/10.1016/j.tetlet.2006.08.086]
[http://dx.doi.org/10.1002/cjoc.201500738]
[http://dx.doi.org/10.14233/ajchem.2015.18915]
[http://dx.doi.org/10.1155/2020/1324096]
[http://dx.doi.org/10.1080/10426500701792933]
[http://dx.doi.org/10.14233/ajchem.2019.21968]
[http://dx.doi.org/10.1134/S1070363218070241]
[http://dx.doi.org/10.1134/S1070363214060309]
[http://dx.doi.org/10.5012/bkcs.2010.31.7.1859]
[http://dx.doi.org/10.3390/molecules21070909] [PMID: 27428939]
[http://dx.doi.org/10.1055/s-2006-951477]
[http://dx.doi.org/10.1007/s13738-018-1541-6]
[http://dx.doi.org/10.1002/aoc.3761]
[http://dx.doi.org/10.3390/M748]
[http://dx.doi.org/10.1007/s11030-018-9892-6] [PMID: 30471013]
[http://dx.doi.org/10.1002/adsc.201700004]
[http://dx.doi.org/10.1039/C5RA15560F]
[http://dx.doi.org/10.1016/j.bmcl.2011.07.123] [PMID: 21890359]
![Wayfinder Image](/images/wayfinder.jpg)